MARKET

RADX

RADX

Radiopharm Theranostics Ltd
NASDAQ
4.510
-0.540
-10.69%
After Hours: 4.600 +0.09 +2.00% 16:04 06/20 EDT
OPEN
4.830
PREV CLOSE
5.05
HIGH
4.880
LOW
4.050
VOLUME
27.07K
TURNOVER
--
52 WEEK HIGH
50.82
52 WEEK LOW
3.496
MARKET CAP
35.55M
P/E (TTM)
-0.3767
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at RADX last week (0609-0613)?
Weekly Report · 4d ago
Bell Potter Remains a Buy on Radiopharm Theranostics Limited (RAD)
TipRanks · 06/11 23:35
Radiopharm granted U.S. FDA FTD for RAD101
TipRanks · 06/11 12:10
Radiopharm Theranostics' RAD101 Receives FDA Fast Track Designation For Imaging Brain Metastases
Benzinga · 06/11 12:10
RADIOPHARM THERANOSTICS GRANTED U.S. FOOD AND DRUG ADMINISTRATION FAST TRACK DESIGNATION FOR RAD101 IMAGING IN BRAIN METASTASES
Reuters · 06/11 12:00
Weekly Report: what happened at RADX last week (0602-0606)?
Weekly Report · 06/09 12:38
Radiopharm announces dosing of first patient in Phase 1 HEAT trial
TipRanks · 06/04 12:16
RADIOPHARM THERANOSTICS DOSES FIRST PATIENT IN PHASE 1 ‘HEAT’ TRIAL OF 177LU-RAD202 FOR TREATMENT OF ADVANCED HER2-POSITIVE SOLID TUMORS
Reuters · 06/04 12:00
More
About RADX
Radiopharm Theranostics Limited is an Australia-based clinical-stage radiotherapeutics company developing a platform of radiopharmaceutical products for diagnostic and therapeutic applications in areas of high unmet medical need. The Company has a pipeline of highly differentiated platform technologies spanning peptides, small molecules and monoclonal antibodies for use in cancer. The clinical program includes one Phase II and three Phase I trials in a variety of solid tumor cancers including lung, breast, and brain. Its technologies include Nano-mAbs, Pivalate, AVB6 Integrin, PSA-mAb, and PTPu. Nano-mAbs is a novel radiopharmaceutical platform made using genetic engineered camelid derived single domain antibodies (sdAb) labelled with a radioisotope of therapeutic radiation. Pivalate is an 18F-FPIA radiotracer, based on a short chain carbohydrate which utilizes the early steps of fatty acid oxidation.

Webull offers Radiopharm Theranostics Ltd stock information, including NASDAQ: RADX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RADX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RADX stock methods without spending real money on the virtual paper trading platform.